BioCryst Pharmaceuticals BCRX Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions.
The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's unrecognized tax benefits decreases resulting from prior period tax positions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's unrecognized tax benefits decreases resulting from prior period tax positions?
- BioCryst Pharmaceuticals (BCRX) reported unrecognized tax benefits decreases resulting from prior period tax positions of $150.75K in Q4 2025.
- What does unrecognized tax benefits decreases resulting from prior period tax positions mean?
- Represents the reduction in liabilities for uncertain tax positions due to the resolution of prior period tax matters. This often occurs when statutes of limitations expire or when tax audits are settled. It indicates the realization of tax certainty and the potential release of previously reserved tax provisions.